- A UPJO is an obstruction or blockage where the kidney and ureter meet.
- When urine cannot drain from the kidney fast enough, it backs up in the kidney.
- UPJO can be treated with a surgery called pyeloplasty. A thin tube called a stent may be placed in the ureter for several weeks to help with healing.
- Antibiotics may be prescribed to prevent a urinary tract infection (UTI) from the stent, but this study found they are not necessary for most children.
For health professionals
- The overall incidence of stent UTI after pyeloplasty is low.
- Antibiotic prophylaxis before pyeloplasty has not been found to decrease the risk of stent UTIs.
- Antibiotic prophylaxis should be reserved for patients with multiple UTI risk factors.
- #1 cause of prenatal hydronephrosis is ureteropelvic junction obstruction (UPJO)
- 1 in 500 newborns screened by ultrasound have UPJO
- 7.59% of patients in the study had stent UTI
Background: the need for antibiotic prophylaxis to prevent urinary tract infections after pyeloplasties are unclear
Ureteropelvic junction obstruction (UPJO) occurs in about 1 in 500 children screened with an antenatal ultrasound. It accounts for about two-thirds of all cases of prenatal hydronephrosis. Surgical correction of UPJO by pyeloplasty can be open or laparoscopic and typically involves placing a temporary stent to ensure adequate drainage and tissue healing.
The reported incidence of postoperative urinary tract infections (UTIs) after pyeloplasty ranges from 2 percent to 15 percent. Clinically insignificant stent biofilms may form on 28 percent to 90 percent of stents. Clear evidence-based guidelines are not available to guide decision-making on whether to prescribe prophylactic antibiotics before stent placement. Two small, single-institution retrospective studies found no significant benefit to prophylactic antibiotic use after pyeloplasty in children.
Children's Hospital Colorado pediatric urology researchers were part of a multi-institution group that reviewed patient records to determine if antibiotic prophylaxis during ureteral stent catheterization decreased the number of stent UTIs.
Methods: comparing outcomes after antibiotic prophylaxis post-pyeloplasty versus no antibiotics
Study authors received records of patients from seven U.S. institutions under age 22 who underwent UPJO and had an internal ureteral stent placed between January 2010 and July 2018.
Data collected included:
- Age at surgery
- under age 4 years (assume diaper use)
- over age 4 years (assume no diaper use)
- Surgical approach
- Prophylactic antibiotic use
- Stent duration
- Foley catheter duration
- Urine culture results
- stent removal
The primary outcome tested was the incidence of stent UTI defined by:
- Urinary symptoms
- Positive urine culture
- while the stent is in place
- at the time of stent removal
Results: comparing the use of antibiotic prophylaxis for pyeloplasty versus no antibiotic prophylaxis
- 338 (50.3%) received antibiotic prophylaxis
- 3.91 years mean age
- 212 (62.7%) likely used diapers
- 180 (53.25) underwent open pyeloplasty
- 102 (30.18%) females
- 38.5 days mean stent duration
- 52/338 (15.4%) had Foley catheter durations longer than two days
- 203/338(60%) received antibiotics during stent removal
- 31/338 (9.17%) had a stent UTI
- 334 (49.7%) no antibiotic prophylaxis
- 6.91 years mean age
- 145 (43.4%) likely used diapers
- 107 (32.04%) underwent open pyeloplasty
- 99 (29.64%) females
- 35.52 days mean stent duration
- 26/334 (7.7%) had Foley catheter durations longer than two days
- 267/334 (79%) received antibiotics during stent removal
- 20/334 (5.99%) had a stent UTI
- 68.65% non-white children received prophylaxis
- 509/672 (75.7%) had ureteral stents removed after four to eight weeks, irrespective of antibiotic use
Overall incidence of stent UTI
- 51 (7.59%) patients in study had stent UTI
- 26 (51%) patients with stent UTIs were female
- 12.9% of females in study had stent UTI
- 5.3% of males in study had stent UTI
- Mean age distribution
- 3.46 years, stent UTI
- 5.56 years, no stent UTI
- Diaper usage
- 10.64% likely using diapers
- 4.13% not likely using diapers
- Positive intraoperative urine culture
- 40% had stent UTI
- 7.12% no stent UTI
- Foley catheter not significantly associated with a stent UTI
- Ureteral stent duration is not significantly associated with a stent UTI
Discussion: prophylactic antibiotics not beneficial to patients after pyeloplasty
Approximately 67 percent of pediatric urologists prescribe prophylactic antibiotics following pyeloplasty without clear patient benefit. In this study, the overall rate of stent UTI was 7.59 percent, including 9.17 percent of children who received antibiotics and 5.99 percent of children who did not. Antibiotic prophylaxis did not reduce the rate of stent UTIs.
Antibiotic prophylaxis did not reduce the risk of stent UTI in these cases.
Factors increasing the percentage of patients receiving antibiotic prophylaxis:
- Younger age
- Diaper use
- Black race
- Open pyeloplasty
Factors not associated with an increase in stent UTIs:
- Surgical approach
- Stent duration, most removed within four to eight weeks
- Foley catheter duration, most removed on postoperative day one
Conclusion: Prophylactic antibiotics did not reduce the risk of stent UTIs
This is the largest known multi-institutional study of the utility of prophylactic antibiotics after pyeloplasty with ureteral stent insertion. The incidence of stent UTIs in the study population was 7.59 percent. The use of prophylactic antibiotics did not reduce the rate of stent UTI even after controlling for risk factors such as female sex, the use of diapers and a positive intraoperative urine culture. Excessive use of antibiotics exposes patients to unnecessary side effects and complications.